RNS Number:9920J
GoldmanSachs International
14 April 2003

EMM DISCLOSURE

                                                             FORM 38.5 (SUMMARY)



Lodge with a RIS and the Takeover Panel.  Use a separate form for each class of
securities in which dealings have been made.





CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS





Name of EMM

Goldman Sachs International




Date of disclosure

14 April 2003




Contact name

Peter Highton




Telephone number

+44 207-774-1935



Please see attached disclosure of dealings under Rule 38.5 in the securities of
the following companies:

Six Continents plc

Cambridge Antibody Technology Group plc





AMENDMENT

If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element(s) of previous disclosure was incorrect:




In the case of option business or dealings in derivatives full details should be
given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date), the
exercise price and any option money paid or received. For derivatives this
should include, at least, the number of reference securities to which they
relate (when relevant), the maturity date (or if applicable the closing out
date) and the reference price.



For full details of the disclosure requirements see Rules 8 and 38 of the Code.
If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129.

Email: monitoring@disclosure.org.uk










                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:

DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS



Dealing in (name of company)

Six Continents plc




Class of security

Ordinary Shares




Date of disclosure

14 April 2003



Date of dealing

11 April 2003



Name of EMM

Goldman Sachs International




Name of offeree/offeror with whom connected

CVC Capital Partners Ltd



Total number of securities purchased

93,000



Highest price paid*

5.9600 # Sterling



Lowest price paid*

5.8500 # Sterling



Total number of securities sold

328,319



Highest price received*

6.0400 # Sterling



Lowest price received*

5.8113 # Sterling



*Currency must be stated




                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:

DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS



Dealing in (name of company)

Cambridge Antibody Technology Group plc




Class of security

Ordinary Shares




Date of disclosure

14 April 2003



Date of dealing

11 April 2003



Name of EMM

Goldman Sachs International




Name of offeree/offeror with whom connected

Oxford Glycosciences plc



Total number of securities purchased

0



Highest price paid*

0.00 # Sterling



Lowest price paid*

0.00 # Sterling



Total number of securities sold

5,000



Highest price received*

3.3500 # Sterling



Lowest price received*

3.3500 # Sterling



*Currency must be stated




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EMMSFEFSLSDSELL